Find practical information about diabetes treatment and management, including blood sugar monitoring, medications, lifestyle changes, complications and everyday diabetes care.
Pharmaceutical giant Eli Lilly has launched its first lawsuits against six US companies, aiming to curb illegal sales of its unapproved weight-loss and diabetes treatment, retatrutide, amid growing risks to consumer safety. Eli Lilly has begun legal action against six…
LilyLink has been chosen to enhance maternal diabetes management in rural New Jersey through a state-backed programme, employing remote glucose monitoring and multilingual support to bridge urban-rural care gaps. LilyLink says it has been selected to help expand maternal diabetes…
Emerging guidance identifies foods to limit, such as sugary drinks and processed foods, emphasising the importance of diet and exercise in managing insulin resistance and delaying type 2 diabetes. People with insulin resistance are often advised to pay close attention…
Emerging research underscores the potential of personalised approaches to improve outcomes for women with gestational diabetes, highlighting the need for integrating genetic, microbiome, and patient preferences into tailored treatment strategies. Gestational diabetes is increasingly being recognised as a major pregnancy…
The UK has approved Foundayo, a once-daily oral GLP-1 medicine from Eli Lilly, making it the first country in Europe to authorise the treatment for obesity-related weight loss and type 2 diabetes, with availability through private prescription later this month.…
Dr Kelvin Candiago highlights the importance of sustained lifestyle changes for type 2 diabetes recovery. His new mGanik Care clinic in Gading Serpong seeks to provide tailored, comprehensive support to improve long-term outcomes and increase remission chances. For many people…
Novo Nordisk has begun supplying Awiqli, its first-of-its-kind once-weekly basal insulin, across US pharmacies, promising a significant shift in type 2 diabetes treatment options after receiving FDA approval. Novo Nordisk has begun supplying Awiqli, its once-weekly basal insulin, to pharmacies…
A team in Hong Kong has developed a microneedle patch that uses ultrasound to track blood glucose levels, offering a low-cost, enzyme-free alternative to traditional sensors with potential applications for broader health monitoring. Researchers in Hong Kong say they have…
Steve Harr outlines four critical questions for Sana Biotechnology’s gene-modified islet cell therapy to revolutionise type 1 diabetes treatment, highlighting challenges in efficacy, manufacturing scale, safety, and economics. Steve Harr has set out four questions he believes will determine whether…
Research from TrialNet indicates that restoring BMI to a healthy range in overweight or obese children and adolescents with early-stage type 1 diabetes could reduce their likelihood of disease progression, highlighting weight management as a modifiable factor in disease risk.…
Abbott has launched Libre Assist, an AI-enabled feature in its diabetes app that predicts how meals may affect blood sugar levels, aiming to shift glucose management from retrospective to real-time decision-making, unveiled at CES in Las Vegas. Abbott has unveiled…
Novo Nordisk has begun distributing Awiqli across the United States, offering adults with type 2 diabetes a groundbreaking once-weekly basal insulin designed to simplify treatment and improve compliance, following regulatory approval and a nationwide rollout. Novo Nordisk has begun rolling…
